Outcome of left heart mechanical valve replacement in West African children--a 15-year retrospective study

Frank Edwin1, Ernest Aniteye, Mark Mawutor Tettey

  • 1National Cardiothoracic Center, Korle Bu Teaching Hospital, P.O. Box KB 846, Accra, Ghana. fedwin68@yahoo.com

Insights

Mechanical valve replacement in West African children shows excellent long-term outcomes, with low mortality and few complications. Left ventricular dysfunction is the main risk factor for early mortality after these pediatric heart surgeries.

Area of Science:

  • Pediatric Cardiology
  • Cardiovascular Surgery
  • Public Health in Developing Nations

Background:

  • West African healthcare infrastructure is limited, posing challenges for pediatric mechanical heart valve replacement.
  • Key concerns include valve-related complications and lifelong anticoagulation management in children.
  • Long-term outcomes of mechanical valve replacement in this pediatric population are not well-documented.

Purpose of the Study:

  • To evaluate the long-term outcomes of mechanical left heart valve replacement in children from West Africa.
  • To assess mortality, valve-related morbidity, and reoperation rates.
  • To identify factors influencing outcomes in this specific patient group.

Main Methods:

  • Retrospective review of pediatric (<18 years) left heart valve replacements from 1993-2008.
  • Study endpoints included mortality, valve-related morbidity, and reoperation.
  • Follow-up data was analyzed for survival and complication rates.

Main Results:

  • 114 children underwent mitral, aortic, or combined valve replacements; ages 6-18 years.
  • Survival rates at 1 and 15 years were 98.1% and 94.0%, respectively.
  • Low rates of prosthetic valve thrombosis (0.56%/patient-year), bleeding (0.9%), and reoperation (0.22%/patient-year) were observed. Preoperative left ventricular dysfunction was linked to mortality.

Conclusions:

  • Mechanical valve replacement in West African children yields excellent survival and low complication rates.
  • Left ventricular dysfunction is a critical predictor of early mortality post-valve replacement.
  • Anticoagulation is generally well-tolerated, with a low risk of bleeding in this setting.
Abstract